An unusual dienone-enol rearrangement product formed during the synthesis of mometasone furoate (Sch 32088)

Steroids

Volumn 63, Issue 3, 1998, Pages 135-140

  Draper, Richard W ^a   Puar, Mohindar S ^a   Vater, Eugene J ^a   McPhail, Andrew T ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Dienone enol rearrangement; Mechanism; Mometasone furoate; NMR; X ray

Indexed keywords

MOMETASONE FUROATE; ANTIINFLAMMATORY AGENT; PHENOL DERIVATIVE; PREGNANE DERIVATIVE;

ARTICLE; CRYSTAL STRUCTURE; DRUG SYNTHESIS; GENE REARRANGEMENT; NUCLEAR MAGNETIC RESONANCE; STEROIDOGENESIS; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

ANTI-INFLAMMATORY AGENTS; CRYSTALLOGRAPHY, X-RAY; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PHENOLS; PREGNADIENEDIOLS;

EID: 0032008574     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(97)00155-4     Document Type: Article

References (16)

1. Shapiro EL, inventor; Schering-Plough Corporation, assignee. 3,20-Dioxo-1,4-diene-17α-ol 17-aromatic heterocycle carboxylates. US Patent 4 472 393. 1984 Sept. 18.
2. Rosenthal D, Duke E. A clinical investigation of the efficacy and safety of mometasone furoate ointment 0.1% versus betamethasone valerate ointment 0.1% in the treatment of psoriasis. Curr Ther Res. 44:1988;790-801.
3. Viglioglia P, Jones ML, Peets EA. Once-daily 0.1% mometasone furoate cream versus twice daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses. J Int Med Res. 18:1990;460-467.
4. Medansky RS, Bressinck R, Cole GW. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis comparison with ointment and cream formulations of flucinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent . Cutis. 42:1988;480-485.
5. Bressinck R, Williams J, Peets EA. Comparison of the effect of mometasone furoate ointment 0.1% and hydrocortisone ointment 1.0%, on adrenocorticoid function in psoriasis patients. Today Ther Trends. 5:1988;25-35.
6. Shapiro EL, Gentles MJ, Tiberi RL, Popper TL, Berkenkopf J, Lutsky BL, Watnick AS. 17-Heteroaroyl esters of corticosteroids. 2. 11β-hydroxy series. J Med Chem. 30:1987;1581-1588.
7. Popper TL, Gentles MJ, Kung TT, Berkenkopf J, Lutsky BL, Watnick AS, Shapiro EL. Structure-activity relationships of a series of novel topical corticosteroids. J Steroid Biochem. 27:1987;837-843.
8. Puar MS, Thompson PA, Ruggeri M, Beiner D, McPhail AT. An unusual rearrangement product formed during production of mometasone furoate (Sch 32088). Steroids. 60:1995;612-614.
9. Ibers JA, Hamilton WC. International Tables for X-Ray Crystallography. Vol. IV:1974;71-151 The Kynoch Press, Birmingham, United Kingdom.
10. Allen FH, Kennard O, Watson DG, Brammer L, Orpen AG, Taylor R. Tables of bond lengths determined by x-ray and neutron diffraction. Part 1. Bond lengths in organic compounds. J Chem Soc Perkin Trans 2. 1987;S1-S19.
11. Whiting DA. Dienone-phenol rearrangements and related reactions. Trost BM. Comprehensive Organic Chemistry. Vol. 3:1991;803-820 Pergamon Press, New York.
12. Ananthanarayan TP, Magnus P, Norman W. Reductive cleavage of the 9,10 bond in 11-oxygenated steroids a new method for the partial synthesis of the Vitamin D skeleton . J Chem Soc Chem Commun. 1983;1096-1098.
13. Takeda K, Tanida H, Horiki K. Preparation of the steroidal 1,4,11 trien-3-ones and a surprisingly rapid dienone-phenol rearrangement. Chem Pharm Bull. 23:1975;2711-2727.
14. Dodson RM, Muir RD. Microbiological transformations. VII. The hydroxylation of steroids at C-9. J Amer Chem Soc. 83:1961;4631-4635.
15. 4,6-3-keto steroids with phenyl(trichloromethyl)mercury. J Org Chem. 35:1970;1060-1064.
16. Denny WA, Kumar V, Meakins GD, Pragnell J, Wicha J. Hydroxy-steroids. Part XVIII. Reactions of 17β-chloro-16α,17α-epoxy-5α-androstane and the preparation of 17β-iodo-16α,17α-epoxy-5α-androstane. J Chem Soc Perkin Trans 1. 1972;486-491.